Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma

References

• Coiffier B, Lepage E, Briere J, . CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–242.
   PubMed Web of Science ®Google Scholar
• Linderoth J, Ehinger M, Jerkeman M, . CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma. Leuk Lymphoma 2007;48:1774–1779.
   PubMed Web of Science ®Google Scholar
• Linderoth J, Jerkeman M, Cavallin-Stahl E, . Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Clin Cancer Res 2003;9:722–728.
   PubMed Web of Science ®Google Scholar
• Rydstrom K, Linderoth J, Nyman H, . CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 2010;51:1643–1648.
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, . Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
   PubMed Web of Science ®Google Scholar
• Linderoth J, Eden P, Ehinger M, . Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma. Br J Haematol 2008;141:423–432.
   PubMed Web of Science ®Google Scholar
• Saal LH, Troein C, Vallon-Christersson J, . BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002;3:software0003–software0003.6.
   PubMed Web of Science ®Google Scholar
• Yang YH, Dudoit S, Luu P, . Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
   PubMed Web of Science ®Google Scholar
• Andersson A, Eden P, Lindgren D, . Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 2005;19: 1042–1050.
   PubMed Web of Science ®Google Scholar
• Fernebro J, Francis P, Eden P, . Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int J Cancer 2006; 118:1165–1172.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57:289–300.
   Google Scholar
• van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2–17.
   PubMed Web of Science ®Google Scholar
• Vestal RE, Wingett D, Knight K, . Expression of CD40 in breast, colon, lung and ovarian tumors. Proc Am Assoc Cancer Res 1997;38:A1550.
   Google Scholar
• Bennett SR, Carbone FR, Karamalis F, . Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478–480.
   PubMed Web of Science ®Google Scholar
• Schultze JL, Cardoso AA, Freeman GJ, . Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA 1995;92:8200–8204.
   PubMed Web of Science ®Google Scholar
• French RR, Chan HT, Tutt AL, . CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat Med 1999;5:548–553.
   PubMed Web of Science ®Google Scholar
• Luczynski W, Kowalczuk O, Ilendo E, . Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. Ann Hematol 2007;86:339–345.
   PubMed Web of Science ®Google Scholar
• Hoves S, Aigner M, Pfeiffer C, . In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray. Leukemia 2009;23:877–885.
   PubMed Web of Science ®Google Scholar
• Mehta AM, Jordanova ES, Kenter GG, . Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008; 57:197–206.
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 2010;277:3864–3875.
   PubMed Web of Science ®Google Scholar
• Schaefer L, Babelova A, Kiss E, . The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005;115:2223–2233.
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright G, Dave SS, . Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008;359:2313–2323.
   PubMed Web of Science ®Google Scholar
• Evens AM, Sehn LH, Farinha P, . Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2010;28: 1017–1024.
   PubMed Web of Science ®Google Scholar
• Ansell SM, Stenson M, Habermann TM, . Cd4 + T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol 2001;19:720–726.
   PubMed Web of Science ®Google Scholar
• Iyengar P, Espina V, Williams TW, . Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005;115:1163–1176.
   PubMed Web of Science ®Google Scholar
• Lu JG, Sun YN, Wang C, . Role of the alpha v-integrin subunit in cell proliferation, apoptosis and tumor metastasis of laryngeal and hypopharyngeal squamous cell carcinomas: a clinical and in vitro investigation. Eur Arch Otorhinolaryngol 2009;266:89–96.
   PubMed Web of Science ®Google Scholar
• Galamb O, Sipos F, Spisak S, . Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes. Cell Oncol 2009;31:19–29.
   PubMed Web of Science ®Google Scholar
• Ishiwata T, Cho K, Kawahara K, . Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer. Oncol Rep 2007;18:537–543.
   PubMed Web of Science ®Google Scholar
• Seya T, Tanaka N, Shinji S, . Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol Rep 2006;16:1225–1230.
   PubMed Web of Science ®Google Scholar
• Kodama J, Hasengaowa, Kusumoto T, . Prognostic significance of stromal versican expression in human endometrial cancer. Ann Oncol 2007;18:269–274.
   PubMed Web of Science ®Google Scholar
• Labropoulou VT, Theocharis AD, Ravazoula P, . Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours. Histopathology 2006;49:582–593.
   PubMed Web of Science ®Google Scholar
• Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010;11:23–36.
   PubMed Web of Science ®Google Scholar
• Rojiani MV, Alidina J, Esposito N, . Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol 2010;3:775–781.
   PubMed Web of Science ®Google Scholar